These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 434672)
1. Dementia, renal failure, and brain aluminum. Arieff AI; Cooper JD; Armstrong D; Lazarowitz VC Ann Intern Med; 1979 May; 90(5):741-7. PubMed ID: 434672 [TBL] [Abstract][Full Text] [Related]
2. Aluminum and the pathogenesis of dialysis encephalopathy. Arieff AI Am J Kidney Dis; 1985 Nov; 6(5):317-21. PubMed ID: 3904424 [No Abstract] [Full Text] [Related]
3. Aluminum and dialysis dementia. Mayor GH Ann Intern Med; 1979 Sep; 91(3):497-8. PubMed ID: 573084 [No Abstract] [Full Text] [Related]
4. The dialysis dementia syndrome and aluminum intoxication. Sideman S; Manor D Nephron; 1982; 31(1):1-10. PubMed ID: 7110469 [No Abstract] [Full Text] [Related]
7. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity. Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553 [TBL] [Abstract][Full Text] [Related]
8. [Current concepts of the role of aluminum in chronic kidney failure patients]. Gruev I; Belovezhdov N Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201 [No Abstract] [Full Text] [Related]
9. Aluminum accumulation in the skin in end-stage renal failure. Ichimaru K; Horie A Nephron; 1987; 46(3):239-42. PubMed ID: 3627317 [TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathophysiologic changes in patients on chronic dialysis: the central nervous system. Kerr DN Adv Nephrol Necker Hosp; 1980; 9():109-32. PubMed ID: 6773310 [No Abstract] [Full Text] [Related]
12. The dialysis encephalopathy syndrome. Possible aluminum intoxication. Alfrey AC; LeGendre GR; Kaehny WD N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532 [TBL] [Abstract][Full Text] [Related]
13. Uremic encephalopathies: clinical, biochemical, and experimental features. Mahoney CA; Arieff AI Am J Kidney Dis; 1982 Nov; 2(3):324-36. PubMed ID: 6756130 [TBL] [Abstract][Full Text] [Related]
14. Tissue accumulation of lanthanum as compared to aluminum in rats with chronic renal failure--possible harmful effects after long-term exposure. Nikolov IG; Joki N; Vicca S; Patey N; Auchère D; Benchitrit J; Flinois JP; Ziol M; Beaune P; Drüeke TB; Lacour B Nephron Exp Nephrol; 2010; 115(4):e112-21. PubMed ID: 20424489 [TBL] [Abstract][Full Text] [Related]
15. Aluminum metabolism and toxicity in renal failure: a review. Mayor GH; Lohr TO; Sanchez TV J Environ Pathol Toxicol Oncol; 1985; 6(1):43-50. PubMed ID: 3906081 [No Abstract] [Full Text] [Related]
16. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Dedman DJ; Treffry A; Candy JM; Taylor GA; Morris CM; Bloxham CA; Perry RH; Edwardson JA; Harrison PM Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):509-14. PubMed ID: 1445209 [TBL] [Abstract][Full Text] [Related]
17. Aluminum loading in children with chronic renal failure. Sedman AB; Miller NL; Warady BA; Lum GM; Alfrey AC Kidney Int; 1984 Aug; 26(2):201-4. PubMed ID: 6503137 [TBL] [Abstract][Full Text] [Related]
18. [Dialysis encephalopathy in chronic renal failure]. Markiewicz K; Bubiński R Pol Tyg Lek; 1980 Jul; 35(30):1159-62. PubMed ID: 7001402 [No Abstract] [Full Text] [Related]